While staking their positions on issues from abortion, to immigration and foreign policy, the candidates also went after each ...

Swiss pharma giant Roche is refocusing its R&D investment on diseases like obesity that weigh heavily on healthcare budgets.

In a study of commonly used treatments for people with multiple sclerosis, both medical and behavioral interventions, and a ...

In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in fatigue. Researchers say ...

Oct. 17, 2024 — In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in ...

Changes in the gene activity of immune cells may help flag people who have multiple sclerosis or are likely to develop it, a ...

The COMBO-MS trial, reported in The Lancet Neurology by Tiffany Braley and colleagues,1 is the first pragmatic, randomised, controlled trial that compares head-to-head the benefits and harms of a ...

Over the past few decades, the quality of life and life expectancy for people with multiple sclerosis (MS) has improved significantly. MS is a neurological condition that affects nearly 1 million ...

Spinogenix is using small molecule drugs to regenerate synapses in patients with ALS, Alzheimer's disease, schizophrenia, ...